The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Overview of attention for article published in The Lancet Respiratory Medicine, August 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

twitter: 3 X users
wikipedia: 1 Wikipedia page

reddit: 1 Redditor
bluesky: 1 Bluesky user

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,182 followers.

The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis… https://t.co/XrTmUbrhTD #nacfc2024

Bravo 👏The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study - The Lancet Respiratory Medicine https://t.co/R1bDiDwKPN

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study - The Lancet Respiratory Medicine https://t.co/0AsjcyzeAt

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.